Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |